Vaccines - STAT

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: The FDA star search, more booster debates, & the future of mRNA

Health By Matthew Herper and Helen Branswell

FDA advisory panel unanimously endorses Moderna’s Covid vaccine booster for some groups

Health By Helen Branswell and Matthew Herper

Tracking the FDA advisory panel meeting on Moderna’s Covid vaccine booster

Health By Matthew Herper

FDA scientists neutral on Moderna Covid-19 vaccine booster ahead of key meeting

Health By Helen Branswell and Gideon Gil

CDC director defends decision to overrule expert panel on Covid booster shots for health and other frontline workers

Pharmalot By Ed Silverman

Moderna plans a vaccine plant in Africa, but critics say the move isn’t enough to ensure access

Health By Matthew Herper

Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment

The Readout LOUD By Adam Feuerstein and Meg Tirrell

Listen: Health equity ‘tourism,’ an $11B biopharma acquisition, & a bony Covid protest

Health By Andrew Joseph

Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate

Health By Helen Branswell

With positive data on mRNA Covid vaccine, Sanofi sets its sights on other pathogens

Matt's Take By Matthew Herper

The Biden administration wants scientific advisers. It just doesn’t like what they have to say

Health By Helen Branswell

Advisory committee recommends wide swath of Americans be offered Covid-19 vaccine boosters

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm’s slow rollout

First Opinion By Arthur L. Caplan

Do we need vaccine exemption boards?

Pharmalot By Ed Silverman

Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports

Health By Matthew Herper

DISTANCED: Pandemic stories of Black life in the rural South

Health By Matthew Herper

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says

Health By Helen Branswell and Matthew Herper

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans

Health By Andrew Joseph

What will the Covid-19 booster rollout look like? Public health groups plan as they await details

Health By Helen Branswell and Matthew Herper

Tracking the FDA advisory panel meeting on Covid-19 booster shots

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

Pharmalot By Casey Ross

Most Read

Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson

A primer on what we know about mixing and matching Covid vaccines

‘Naively ambitious’: How COVAX failed on its promise to vaccinate the world

How the risk of side effects could change with Covid-19 vaccine boosters

Winter is coming, again: What to expect from Covid-19 as the season looms

With science and scripture, a Baltimore pastor is fighting Covid-19 vaccine skepticism

I was once a hardcore anti-vaxxer. Now I try to nudge people to get the Covid-19 vaccine

If Covid-19 vaccines can cause heart inflammation, caution should be warranted in those at risk

All Coverage

Listen: The FDA star search, more booster debates, & the future of mRNA

FDA advisory panel unanimously endorses Moderna’s Covid vaccine booster for some groups

Tracking the FDA advisory panel meeting on Moderna’s Covid vaccine booster

FDA scientists neutral on Moderna Covid-19 vaccine booster ahead of key meeting

CDC director defends decision to overrule expert panel on Covid booster shots for health and other frontline workers

Moderna plans a vaccine plant in Africa, but critics say the move isn’t enough to ensure access

Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment

Listen: Health equity ‘tourism,’ an $11B biopharma acquisition, & a bony Covid protest

Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate

With positive data on mRNA Covid vaccine, Sanofi sets its sights on other pathogens

The Biden administration wants scientific advisers. It just doesn’t like what they have to say

Advisory committee recommends wide swath of Americans be offered Covid-19 vaccine boosters

Listen: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm’s slow rollout

Do we need vaccine exemption boards?

Pharmalittle: J&J says its Covid-19 shot is more effective in two doses; India plans to resume Covid-19 vaccine exports

Johnson & Johnson says additional dose boosts Covid vaccine efficacy

A community pioneer lost, and remembered

The Guardian of the Glades

DISTANCED: Pandemic stories of Black life in the rural South

Pfizer Covid-19 vaccine generates robust antibody response in children, without serious safety issues, company says

FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans

What will the Covid-19 booster rollout look like? Public health groups plan as they await details

Tracking the FDA advisory panel meeting on Covid-19 booster shots

Listen: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

Pharmalittle: FDA scientists skeptical on boosters; moderate Democrats sink Pelosi’s drug pricing proposal